Why Your Preferred Targeted Drugs May Become UnaffordablePICCART, Martine J.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 19, pp 5849-5851, issn 0008-5472, 3 p.Article

Targeted drug-carrying bacteriophages as antibacterial nanomedicinesYACOBY, Iftach; BAR, Hagit; BENHAR, Itai et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2156-2163, issn 0066-4804, 8 p.Article

Novel Drugs and Drug Targets to Treat InflammationBasic & clinical pharmacology & toxicology (Print). 2014, Vol 114, Num 1, pp 137-145, issn 1742-7835, 9 p.Conference Paper

Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discoveryKORCSMAROS, Tamás; FARKAS, Illés J; SZALAY, Máté S et al.Bioinformatics (Oxford. Print). 2010, Vol 26, Num 16, pp 2042-2050, issn 1367-4803, 9 p.Article

Bugging tumors to put drugs on targetJULIANO, Rudy.The New England journal of medicine. 2007, Vol 356, Num 9, pp 954-955, issn 0028-4793, 2 p.Article

Molecular Pathways: Translational Potential of Deubiquitinases as Drug TargetsD'ARCY, Pádraig; LINDER, Stig.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 3908-3914, issn 1078-0432, 7 p.Article

Computational biology approaches for selecting host―pathogen drug targetsBROWN, James R; MAGID-SLAV, Michal; SANSEAU, Philippe et al.Drug discovery today. 2011, Vol 16, Num 5-6, pp 229-236, issn 1359-6446, 8 p.Article

Membrane lipidomics for the discovery of new antiparasitic drug targetsMARECHAL, Eric; RIOU, Mickaël; KERBOEUF, Dominique et al.Trends in parasitology. 2011, Vol 27, Num 11, pp 496-504, issn 1471-4922, 9 p.Article

Visualizing the drug target landscapeCAMPBELL, Stephen J; GAULTON, Anna; MARSHALL, Jason et al.Drug discovery today. 2010, Vol 15, Num 1-2, pp 3-15, issn 1359-6446, 13 p.Article

Thérapeutiques cibléesDELBALDO, Catherine; PIEDBOIS, Pascal.La Revue du praticien. Médecine générale. 2009, Num 823, pp 395-397, issn 0989-2737, 3 p.Article

Caveolae: An alternative endocytotic pathway for targeted drug deliveryBATHORI, Gyorgy; CERVENAK, Laszlo; KARADI, Istvan et al.Critical reviews in therapeutic drug carrier systems. 2004, Vol 21, Num 2, pp 67-95, issn 0743-4863, 29 p.Article

A Forensic Analysis of Drug Targets From 2000 Through 2012MUNOS, B.Clinical pharmacology and therapeutics. 2013, Vol 94, Num 3, pp 407-411, issn 0009-9236, 5 p.Article

Properties and identification of human protein drug targetsBAKHEET, Tala M; DOIG, Andrew J.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 4, pp 451-457, issn 1367-4803, 7 p.Article

Schistosomes―proteomics studies for potential novel vaccine and drug targetsDEMARCO, Ricardo; VERJOVSKI-ALMEIDA, Sergio.Drug discovery today. 2009, Vol 14, Num 9-10, pp 472-478, issn 1359-6446, 7 p.Article

Unfinished business : target-based drug discoveryBROWN, David.Drug discovery today. 2007, Vol 12, Num 23-24, pp 1007-1012, issn 1359-6446, 6 p.Article

Target-based drug discovery: is something wrong ?SAMS-DODD, Frank.Drug discovery today. 2005, Vol 10, Num 2, pp 139-147, issn 1359-6446, 9 p.Article

The adipocyte as a drug discovery targetNAWROCKI, Andrea R; SCHERER, Philipp E.Drug discovery today. 2005, Vol 10, Num 18, pp 1219-1230, issn 1359-6446, 12 p.Article

Thrombospondins, Potential Drug Targets for Cardiovascular DiseasesMUSTONEN, Erja; RUSKOAHO, Heikki; RYSÄ, Jaana et al.Basic & clinical pharmacology & toxicology (Print). 2013, Vol 112, Num 1, pp 4-12, issn 1742-7835, 9 p.Article

Histone acetyl transferases as emerging drug targetsDEKKER, Frank J; HAISMA, Hidde J.Drug discovery today. 2009, Vol 14, Num 19-20, pp 942-948, issn 1359-6446, 7 p.Article

Modulating receptor function through RAMPs : can they represent drug targets in themselves?SEXTON, Patrick M; POYNER, David R; SIMMS, John et al.Drug discovery today. 2009, Vol 14, Num 7-8, pp 413-419, issn 1359-6446, 7 p.Article

Aquaporins as targets for drug discoveryCASTLE, Neil A.Drug discovery today. 2005, Vol 10, Num 7, pp 485-493, issn 1359-6446, 9 p.Article

Enhancement of radiotherapy with DNA topoisomerase I-targeted drugsCHEN, Allan Y; CHOU, Rachel; SHIH, Shyh-Jen et al.Critical reviews in oncology/hematology. 2004, Vol 50, Num 2, pp 111-119, issn 1040-8428, 9 p.Article

What are the reasons for negative phase III trials of molecular-target-based drugs?SAIJO, Nagahiro.Cancer science. 2004, Vol 95, Num 10, pp 772-776, issn 1347-9032, 5 p.Article

Le prospettive nel futuro della tecnologia farmaceutica = Future perspective in pharmaceutical technologySANTUS, G.La Chimica e l'industria (Milano). 1998, Vol 80, Num 9, pp 1203-1207, issn 0009-4315Article

Analysis on the current status of targeted drug delivery to tumorsIL KEUN KWON; SANG CHEON LEE; HAN, Bumsoo et al.Journal of controlled release. 2012, Vol 164, Num 2, pp 108-114, issn 0168-3659, 7 p.Conference Paper